IBL Finance Limited
Promoters Mr.Nikhilkumar Y Thakkar · Mr. Amitbhai Shabhulal Thakkar · Mr. Bhagyesh Kirtibhai Parekh · Mr. Bharatkumar V Thakkar
Against an issue price of ₹84. Split- and bonus-adjusted official closes — a past move, never a forecast.
IBL Finance Limited raised ₹10 crore through a SME-platform initial public offer.
The filing places it in Pharmaceuticals & Biotechnology and names four promoters: Mr.Nikhilkumar Y Thakkar, Mr. Amitbhai Shabhulal Thakkar, Mr. Bhagyesh Kirtibhai Parekh and Mr. Bharatkumar V Thakkar.
The book was open from 7 November 2023 to 9 November 2023.
The issue was priced at ₹84 a share.
The whole offer is a fresh issue of shares — ₹11 crore raised by the company itself.
The issuer reported the offer subscribed 57.0 times the shares on offer. That is its own final figure, filed with the exchange after the book closed — not a reading we took while bidding was open.
The shares listed on 20 November 2023.
The last official close on file is ₹38.05 (11 September 2026), which is 54.7% below the issue price.
It now trades as SUNREST, and its filed financials are on its company page.
Shares sold in the issue at ₹84 last closed at ₹38.05.
See SUNREST’s filed financials and price history →Official exchange closes, restated for splits, bonuses and rights issues since listing. A record of past price movement, not a forecast.
No offer-for-sale leg — every share in this offer is newly issued, so the whole amount raised goes to the company.
- How it was priced
- Fixed price — the price was set in advance, with no band to bid inside
- Listing sought at
- NSE
- Designated exchange
- NSE
- Discount
- None offered
- Registered office
- Western India
- Company website
- http://www.sunrestlifescience.com/
- Registrar
- Skyline Financial Services Private Limited
- Lead manager
- Mark Corporate Advisors Private Limited
- Bidding opens7 Nov 2023
- Bidding closes9 Nov 2023
- Basis of allotmentnot published
Not published in the exchange feeds we ingest — we do not estimate it.
- Listing20 Nov 2023
This is the issuer’s own final figure, filed with the exchange once bidding had closed — not a reading we took while the book was open. The exchange publishes only a running cumulative figure and no history, so for an issue nobody polled live this filing is the only account of the book that exists. It covers the whole offer and carries no breakdown by category and no timestamp.
- Non-institutional investors47.5%6,12,800 sh
- Retail individual investors47.5%6,12,800 sh
- Market maker5.1%65,600 sh
No part of the offer was set aside for anchor investors, qualified institutional buyers, reserved portion or other.
The portion of the offer set aside for each category before bidding opened, as the issuer filed it. The anchor allocation is filed as its own line rather than inside the institutional one, so these add up to the whole offer. Shares as filed; the percentages are computed against the offer's own share count.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We have not extracted an anchor allotment list for this issue.
- All other pre-issue capitalSEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment20 May 2024already free
- Promoters' minimum contributionSEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment20 May 2025already free
Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.
The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
The offer document must name the listed companies the issuer considers comparable, and print their valuation figures beside its own. This is that list — the issuer’s choice of comparison, not ours.
| Company | P/E | P/B | RoNW | EPS | Income |
|---|---|---|---|---|---|
| Apollo Finvest (India) Limited (Standalone)not in our universe | 29.6 | 7.1 | 24.1% | 27.01 | ₹4,615 cr |
| Arman Financial Service Limited (Consolidated)not in our universe | 23.6 | 5.9 | 25.7% | 110.47 | ₹42,390 cr |
| CSL Finance Limited (Consolidated)not in our universe | 21.1 | 2.6 | 12.6% | 22.02 | ₹11,753 cr |
| MAS Financial Services Limited (Consolidated)not in our universe | 23.4 | 3.1 | 13.6% | 37.18 | ₹99,026 cr |
| Ugro Capital Limited | 48.2 | 2.6 | 4.0% | 5.69 | ₹48,291 cr |
The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.
Figures as PRINTED by the issuer in its own offer document. The comparison set is the issuer's choice, not ours.
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Mark Corporate Advisors Private Limited 2023 – 2025 | 5 0 measurable | — | — | — | — |
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Skyline financial services private limited 2021 – 2026 | 79 2 measurable | +12.3% | 0 of 2 | 1 of 2 | 1 of 4 |
A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.
- Prospectus· PDF · exchange archive5 Jan 2024
- Draft red herring prospectus (DRHP)· ZIP · exchange archive16 Aug 2023
- In-principle approval (XBRL)· XML · exchange archive
- Listing filing (XBRL)· XML · exchange archive
Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.
Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.